Completed NA INTERVENTIONAL 1-arm NCT02405988

Pharmacodynamics and Arteriovenous Differences of Naloxone in Healthy Participants Exposed to an Opioid (OPI-15-001)

Sponsor: Norwegian University of Science and Technology

Interventions Intravenous naloxone Remifentanil

Updated 6 times since 2017 Last updated: Aug 27, 2018 Started: Apr 30, 2015 Primary completion: Feb 29, 2016 Completion: Feb 29, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Drug Overdose and is currently completed. Norwegian University of Science and Technology leads this study, which shows 6 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Sep 2018 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Sep 2018 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Apr 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Norwegian University of Science and Technology
St. Olavs Hospital

Data source: Norwegian University of Science and Technology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Trondheim, Norway